Highlighted Initiatives
The National Center to Accelerate Cures (NCAC) announced its official launch on October 1st, 2026 as a national initiative dedicated to advancing New Approach Methodologies (NAMs) toward regulatory acceptance. The Center is funded by $3 million in congressionally directed funding secured by U.S. Senators (Maryland) Chris Van Hollen and Angela Alsobrooks and is housed at Blackbird BioHub in Baltimore.
NCAC is a partnership among three nonprofit organizations: Blackbird Laboratories, Critical Path Institute® (C-Path) and the Arrowpoint Labs Foundation. Together, they give NAMs developers a national resource, a place where promising novel drug development tools can generate the regulatory-grade evidence packages the FDA requires before formally accepting them.
Our Work
Talent and ideas are more geographically distributed than private capital and economic impact. Arrowpoint Labs Foundation works at the intersection of scientific innovation and place-based economic development to cultivate local infrastructure and unlock economic potential across the country. Our mission is to ensure that the wealth innovation creates remains connected to the places and people who built it.
Our Leadership
Abishek Kulshreshtha Ph.D.
Partner, Co-Founder
Arrowpoint Labs LLC
Tayo Sanders II Ph.D.
Partner, Co-Founder
Arrowpoint Labs LLC
Winston S. Kirkton J.D.
Partner
BakerHostetler LLP
Maaike Everts Ph.D.
Executive Director
Critical Path Institute
John Ho Ph.D.
Founder
ven^x
© 2025. All rights reserved.